Skip to main content
36°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
31.54
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
24
25
Next >
HIMS Stock Breaks Out On Powerful Turnaround Quarter
February 27, 2024
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum
Via
Investor's Business Daily
Bitcoin Above $55K Gets Marathon, Riot Platforms Trending — Zoom Video, Hims & Hers, Tesla Also On Investors' Radars Today
February 26, 2024
On Monday, the leading U.S. indices concluded on a negative note, with the Dow Jones Industrial Average finishing 0.16% down at 39,069.23, the S&P 500 dropping nearly 0.4% to 5,069.53, and the Nasdaq...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates
February 26, 2024
Hims & Hers Health reported quarterly earnings of 1 cent per share which beat the analyst consensus estimate of losses of 3 cents per share. The company reported quarterly sales of $246.62 million...
Via
Benzinga
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Monday's After-Market Session
February 26, 2024
Via
Benzinga
Earnings Preview: Hims & Hers Health
February 23, 2024
Via
Benzinga
Where Will Hims & Hers Stock Be in 5 Years?
January 15, 2024
This unique telemedicine company looks poised for a bright future.
Via
The Motley Fool
1 Healthcare Stock to Buy Hand Over Fist Going Into 2024
December 08, 2023
Hims & Hers Health is growing at an unprecedented rate.
Via
The Motley Fool
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 26, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
This healthcare stock making a buzz with 160% growth
February 26, 2024
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
February 20, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
February 05, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Earnings Scheduled For February 26, 2024
February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
Via
Benzinga
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
January 25, 2024
Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
7 Growth Stocks to Buy and Hold Forever: January 2024
January 23, 2024
Growth stocks haven't kept up with wider market growth, creating a unique opportunity to capture long-term upside with these companies.
Via
InvestorPlace
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
January 22, 2024
Healthcare is nearly a fifth of America's economy. Ride these high-flying healthcare stocks to monster gains.
Via
The Motley Fool
Topics
Economy
Exposures
Economy
3 Stocks to Profit from the Telehealth Transformation
January 12, 2024
Telehealth stocks capture healthcare and medicine's future but don't bet the bank on a company that can't cut it.
Via
InvestorPlace
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
January 11, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Underestimating This Stock Could Be Wall Street's Biggest Mistake in 2024
January 02, 2024
Hard numbers and the CEO's own words point to shares exploding next year.
Via
The Motley Fool
Weight Watchers gains from Oprah’s GLP-1 weight-loss
January 02, 2024
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2023 Year In Review
January 02, 2024
The S&P 500 had a strong year in 2023, returning about 24% to investors from the beginning of the year to the end. Some of that was a bounce back from a poor 2022 when it was down over 11%.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
The 3 Hottest Telehealth Stocks to Watch in 2024
January 01, 2024
Uncover the hottest telehealth stocks for 2024, on the back of a market projected to reach a whopping $504.2 billion by 2030.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
Via
Benzinga
LifeMD expands telehealth GLP-1weight-loss service with Medifast
December 19, 2023
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing
Via
MarketBeat
My 2024 Financial Resolution: Buying More of These 3 Stocks
December 11, 2023
These stocks are still screaming buys for my long-term portfolio.
Via
The Motley Fool
Ozempic vs. Mounjaro:: Battle of the bulge
December 04, 2023
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage
Via
MarketBeat
Exposures
Product Safety
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
December 04, 2023
From
Hims & Hers Health, Inc.
Via
Business Wire
This Growth Stock Could 10x in 10 Years
November 29, 2023
This emerging consumer healthcare company could compound at more than 25% annually.
Via
The Motley Fool
Hims & Hers earnings highlight expanded personalized treatments
November 29, 2023
E-health and wellness platform operator Hims & Hers Inc. reported a stellar quarter of growth that highlighted its expanded line of personalized products
Via
MarketBeat
5 Telehealth Stocks That Have Nothing But Upside
November 26, 2023
Dive into the dynamic world of top telehealth stocks. Discover our expert analysis on the gems shaping the future of digital healthcare.
Via
InvestorPlace
My Take: 4 Strong Growth Stocks to Buy This Week
November 26, 2023
Be thankful for Wall Street's discounts on these potential market-beating stock ideas.
Via
The Motley Fool
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
24
25
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.